Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
filingDate |
2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10736b3a611c053fe5bf138c5887f474 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43892020d453c6c351f460c5af5244a |
publicationDate |
2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015231154-A1 |
titleOfInvention |
Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement |
abstract |
The present invention relates to a transdermal therapeutic system for applying the active ingredient norelgestromin onto the skin, optionally in combination with estrogens. It further relates to the use of such systems for hormonal contraception, and for hormone replacement therapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11337932-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980753-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019336454-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033512-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648213-B2 |
priorityDate |
2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |